| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8381805eba6d034fc77bd230dd02e6e2 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-573 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-573 |
| filingDate |
2005-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be8a9e48755c1d6a72821532f4f97736
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d7d39090838e6a4c1f77b01f2fa0d47e |
| publicationDate |
2006-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2006019936-A1 |
| titleOfInvention |
Methods and compositions for treating cancer |
| abstract |
The invention provides compounds and methods for treating cancer. Exemplary compounds are multi-functional compounds with two different moieties connected by a linker. Compounds of the invention can activate one or more pathways that result in the inhibition of cell growth. The invention includes cytostatic and cytotoxic compounds. Methods and compositions of the invention are particularly useful for treating cancer cells that are resistant to other chemotherapeutic drugs. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015057894-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9982009-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2018362574-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011017106-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2015105361-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11560535-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2019292495-A1 |
| priorityDate |
2004-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |